Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to $912000.0.

  • Assembly Biosciences' Change in Receivables changed N/A to $912000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $869000.0, marking a year-over-year change of. This contributed to the annual value of -$43000.0 for FY2024, which is 9522.75% up from last year.
  • Assembly Biosciences' Change in Receivables amounted to $912000.0 in Q3 2025.
  • Over the past 5 years, Assembly Biosciences' Change in Receivables peaked at $912000.0 during Q3 2025, and registered a low of -$1.0 million during Q1 2021.
  • Over the past 5 years, Assembly Biosciences' median Change in Receivables value was -$22000.0 (recorded in 2022), while the average stood at -$22714.3.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 11830.57% in 2022, then crashed by 3740000.0% in 2023.
  • Assembly Biosciences' Change in Receivables (Quarter) stood at -$433000.0 in 2021, then surged by 30.25% to -$302000.0 in 2022, then surged by 114.24% to $43000.0 in 2023, then tumbled by 200.0% to -$43000.0 in 2024, then soared by 2220.93% to $912000.0 in 2025.
  • Its last three reported values are $912000.0 in Q3 2025, -$43000.0 for Q2 2024, and $43000.0 during Q4 2023.